Corrigendum: â€œHigh-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II â€“ The Total Macular Volume. The First Follow-Up Study Over 2 Yearsâ€ by Nermin Serbecic et al.
GENERAL COMMENTARY
published: 04 June 2015
doi: 10.3389/fneur.2015.00131
Edited and reviewed by:
Kenneth Shindler,
University of Pennsylvania, USA
*Correspondence:
Fahmy Aboulenein-Djamshidian and
Sven C. Beutelspacher
fahmy.aboul-enein@telering.at;
sven.beutelspacher@gmail.com
Specialty section:
This article was submitted to
Neuro-Ophthalmology, a section of
the journal Frontiers in Neurology
Received: 14 May 2015
Accepted: 20 May 2015
Published: 04 June 2015
Citation:
Serbecic N,
Aboulenein-Djamshidian F,
Beutelspacher SC, Khan A, Vass C,
Kristoferitsch W, Reitner A and
Schmidt-Erfurth U (2015)
Corrigendum: “High-resolution
spectral domain-optical coherence
tomography in multiple sclerosis,
part II – the total macular volume.
The first follow-up study over 2 years”.
Front. Neurol. 6:131.
doi: 10.3389/fneur.2015.00131
Corrigendum: “High-resolution
spectral domain-optical coherence
tomography in multiple sclerosis,
part II – the total macular volume.
The first follow-up study over
2 years”
Nermin Serbecic1, Fahmy Aboulenein-Djamshidian2*, Sven C. Beutelspacher 3*,
Adnan Khan4, Clemens Vass1, Wolfgang Kristoferitsch2, Andreas Reitner 1 and
Ursula Schmidt-Erfurth1
1 Department of Ophthalmology, Medical University of Vienna, Vienna, Austria, 2 Department of Neurology, SMZ-Ost Donaus-
pital, Vienna, Austria, 3 Department of Ophthalmology, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim,
Germany, 4 Nuffield Department of Surgical Sciences, Division of Medical Sciences, University of Oxford, Oxford, UK
Keywords: multiple sclerosis, optical coherence tomography, retinal nerve fiber layer thickness, total macular
volume, spectral domain, time domain, heterogeneity, individual differences
A corrigendum on
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A Corrigendum on the Affiliation
The affiliations for Wolfgang Kristoferitsch and Fahmy Aboul-Enein is:
Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, SMZ-Ost
Donauspital, Langobardenstrasse 122, 1220 Wien, Austria
A Corrigendum on Figure 2
As we confused the terms “RNFL” and “TMV” in the figure legend and submitted the incorrect
image for Figure 2, we have to re-submit Figure 2 and correct the figure legend for Figure 2 as follows:
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FIGURE 2 | Variation of global TMV measurements. (A,B) variation
of TMV measurements between baseline and follow-up examination in
relation to the total relapses (without ON) before study entry.
(C,D) variation of TMV measurements between baseline and follow-up
examination in relation to the relapses (without ON) during the
observation period. (A) left eye; (B) right eye; (C) left eye; (D) right eye;
white squares, RRMS without ON; black squares, RRMS with ON;
white triangles, SPMS without ON; black triangles, SPMS with ON.
However, neither the raw data nor their interpretations have thus be
changed.
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